about
Incorporated in 1978, Biocon is engaged in the manufacture of biotechnology products and research services. The company's business include Generics with diverse portfolio encompasses a wide range of complex molecules, including cardiovascular medicat...
Read More
396.85
1.70
(0.43%)
3.6M
NSE+BSE Volume
NSE 21 Nov, 2025 3:31 PM (IST)
Analyst Downgrade
Citibank downgrades Biocon to a 'Sell' call from 'Buy', lowers target price to Rs 360 per share
See details